Progress in the study of septic cardiomyopathy

doi:10.3877/cma.j.jssn.2096-1537.2016.03.013

Abstract

Abstract:

Septic cardiomyopathy has high incidence and poor outcomes. Many experimental and clinical studies have been conducted in the fields of septic cardiomyopathy but the pathogenesis and therapeutic options remain unclear and controversial. In this editorial article, we will summarize the findings of previous studies and discuss the pathogenesis, hemodynamic changes, diagnosis and potential therapeutic recommendation in septic cardiomyopathy, aiming to to help continue further research in our understanding of septic cardiomyopathy at a more comprehensive level.

Key words: Sepsis, Shock, Cardiomyopathy, Ultrasound

Nianfang Lu, Xiuming Xi. Progress in the study of septic cardiomyopathy[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2016, 02(03): 199-204.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.jssn.2096-1537.2016.03.013

https://icu.cma-cmc.com.cn/EN/Y2016/V02/I03/199

References 40

[1]	Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8):801–810.
[2]	李真玉, 陈兵. 脓毒症心肌抑制的诊治进展. 中国循环杂志, 2015, 30(7):705–707.
[3]	Cunnion RE, Schaer GK, Parker MM, et al. The coronary circulation in human septic shock[J]. Circulation, 1986, 73(4):637–644.
[4]	Vieillard-Baron A. Septic cardiomyopathy[J]. Ann Intensive Care, 2011, 1(1):6.
[5]	Kakihana Y, Ito T, Nakahara M, et al. Sepsis-induced myocardial dysfunction: pathophysiology and management[J]. J Intensive Care, 2016, 4(1):22.
[6]	Pathan N, Franklin JL, Eleftherohorinou H, et a1. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase[J]. Crit Care Med, 2011, 39(7):1692–1711.
[7]	Barth E, Radermacher P, Thiemermann C, et al. Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock[J]. Crit Care Med, 2006, 34(2):307–313.
[8]	李莉, 严静, 陈昌勤, 等. 线粒体损伤在脓毒症大鼠心肌细胞凋亡中的作用[J]. 中华急诊医学杂志, 2012, 21(11):1221–1225.
[9]	HobaiI A, Edgecomb J, LaBarge K, et a1. Dysregulation of intracellular calcium transporters in animal models of sepsis induced cardiomyopathy[J]. Shock, 2015, 43(1):3–15.
[10]	MacKenzie A. Endothelium-derived vasoactive agents, AT1 receptors and inflammation[J]. Pharmacol Ther, 2011, 131(2):187–203.
[11]	Salgado DR, Rocco JR, Silva E, et a1. Modulation of the reninangiotensin-aldosterone system in sepsis: a new therapeutic approach[J]? Expert Opin Ther Targets, 2010, 14(1):11–20.
[12]	Jabot J, Monnet X, Bouchra L, et al. Cardiac function index provided by transpulmonary thermodilution behaves as an indicator of left ventricular systolic function[J]. Crit Care Med, 2009, 37(11):2913–2918.
[13]	Wang J, Ji W, Xu Z, et al. Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis[J]. Exp Ther Med, 2016, 11(1):154–156.
[14]	Parker MM, McCarthy KE, Ognibene FP, et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans[J]. Chest, 1990, 97(1):126–131.
[15]	Bouhemad B, Nicolas RA, Arbelot C, et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction[J]. Crit Care Med, 2009, 37(2):441–447.
[16]	Røsjø H, Varpula M, Hagve TA, et al. The FINNSEPSIS Study Group. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome[J]. Intensive Care Med, 2011, 37(1):77–85.
[17]	Lorigados CB, Soriano FG, Szabo C. Pathomeehanisms of myocardial dysfunction in sepsis[J]. Endocr Metab Immune Disord Drug Targets, 2010, 10(3):274–284.
[18]	Merx MW, Weber C. Sepsis and the heart[J]. Circulation, 2007, 116(7):793–802.
[19]	Kalbitz M, Grailer JJ, Fattahi F, et al. Role of extracellular histones in the cardiomyopathy of sepsis[J]. FASEB J, 2015, 29(5):2185–2193.
[20]	Alhamdi Y, Abrams ST, Cheng Z, et al. Circulating histones are major mediators of cardiac injury in patients with sepsis[J]. Crit Care Med, 2015.43(10):2094–2103.
[21]	Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography[J]. Eur J Echocardiogr, 2009, 10(2):165–193.
[22]	Ng PY, Sin WC, Ng AK, et al. Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS)[J]. Crit Care, 2016, 20(1):145.
[23]	Delphine H, Martin K, Julien N, et al. Comparison of real-time three dimensional speckle tracking to magnetic resonance imaging in patients with coronary heart disease[J]. Am J Cardiol, 2012, 109(2):180–186.
[24]	Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock[J]. Ann Intern Med, 1984, 100(4):483–490.
[25]	Jardin F, Brun-Ney D, Auvert B, et al. Sepsis-related cardiogenic shock[J]. Crit Care Med, 1990, 18(10):1055–1060.
[26]	Repessé X, Charron C, Vieillard BA. Evaluation of left ventricular systolic function revisited in septic shock[J]. Crit Care, 2013, 17(4):164–167.
[27]	Bouhemad B, Nicolas RA, Arbelot C, et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction[J]. Crit Care Med, 2009, 37(2):441–447.
[28]	Landesberg G, Gilon D, Meroz Y, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock[J]. Eur Heart J, 2012, 33(7):895–903.
[29]	Bouhemad B, Nicolas-Robin A, Arbelot C, et al. Isolated and reversible impairment of ventricular relaxation in patients with septic shock[J]. Crit Care Med, 2008, 36(3):766–774.
[30]	Kimchi A, Ellrodt AG, Berman DS, et al. Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study[J]. J Am Coll Cardiol, 1984, 4(5):945–951.
[31]	Hogue B, Chagnon F, Lesur O. Resuscitation fluids and endotoxin-induced myocardial dysfunction: is selection a load-independent differential issue[J]? Shock, 2012, 38(3):307–313.
[32]	Morelli A, De Castro S, Teboul JL, et a1. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression[J]. Intensive Care Med, 2005, 31(5):638–644.
[33]	Avgeropoulou C, Andreadou I, Markantonis KS, et al. The Ca-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine[J]. Eur J Heart Fail, 2005, 7(5):882–887.
[34]	Hamzaoui O, Georger JF, Monnet x, et a1. Early administration of norepinephrine increases cardiac preload and cardiac 0utput in septic patients with life-threatening hypotension[J]. Crit Care, 2010, 14(4):R142.
[35]	De Backer D, Aldecoa C, Njimi H, et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis[J]. Crit Care Med, 2012, 40(3):725–730.
[36]	Dellinger RP, Levy MM, Rhodes A, et a1. Surviving sepsis Campaign: international guidelines for management of severe sepsis and septic shock2012[J]. Intensive Care Med, 2013, 39(2):165–228.
[37]	Solomon SB, Minneci PC, Deans KJ, et al. Effects of intra-aortic balloon counterpulsation in a model of septic shock[J]. Crit Care Med, 2009, 37(1):7–18.
[38]	郭炜, 盛博, 赵磊, 等. 主动脉球囊反搏术在感染性休克患者抢救治疗中的应用价值. 中国危重病急救医学, 2012, 24(1):46–49.
[39]	Pořízka M, Kopecký P, Prskavec T, et al. Successful use of extra-corporeal membrane oxygenation in a patient with streptococcal sepsis: a case report and review of literature[J]. Prague Med Rep, 2015, 116(1):57–63.
[40]	Fujisaki N, Takahashi A, Arima T, et al. Successful treatment of panton-valentine leukocidin-expressing Staphylococcus aureus-associated pneumonia co-infected with influenza using extracorporeal membrane oxygenation[J]. In Vivo, 2014, 28(5):961–965.

Please choose a citation manager

Content to export